Variables | Data |
---|---|
Mean follow-up ± SD (min–max), months | 6.91 ± 3.41 (1.0–12.0) |
Maximum diameter of AMLs, cm | |
Before SAE, median (min–max) | 13.9 (6.60–25.5) |
After SAE, median (min–max) | 10.7 (4.7–30.0) |
Maximum diameter reduction | |
Median (min–max), cm | 1.8 (− 7.2–7.0) |
Median (min–max), (%) | 16.0 (− 32.58–59.83) |
Volume of AMLs, cc | |
Before SAE, median (min–max) | 715.91 (134.18–3533.81) |
After SAE, median (min–max) | 283.89 (37.33–6322.45) |
Volume reduction | |
Median (min–max), cc | 213.1 (− 3266.67–1711.69) |
Median (min–max), (%) | 48.44 (− 106.9–94.17) |
Serum creatinine level, mL/min | |
Before SAE, median (min–max) | 0.8 (0.5–2.8) |
After SAE, median (min–max) | 0.7 (0.40–3.1) |
Hemoglobin level, g/dL | |
Before SAE, mean ± SD | 9.84 ± 2.29 |
After SAE, mean ± SD | 10.72 ± 1.44 |
Leucocytic count (103/uL) | |
Before SAE, mean ± SD | 10.56 ± 3.43 |
After SAE, mean ± SD | 10.07 ± 3.38 |
Hospital stay duration, median (min–max) days | 6.0 (1.0–20.0) |